Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.
This paper presents the status quo of cryptocurrency-themed malicious extensions and unveils the characteristics that can ...
Background Mixed connective tissue disease (MCTD) has long been debated as an early nonspecific phase/symptom of ...
Invesco highlights strategic fund shifts and key contributors driving Q3 growth. Explore how smart repositioning supports ...
Invesco reviews Q3 2025 performance for ACEIX, highlighting sector-driven underperformance and new growth-focused holdings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback